Methods
We collected clinical data on all patients under the age of 14 years
with a diagnosis of KMT2A-rearranged AML treated by Pediatric Hematology
/ Oncology Department at the King Faisal Specialist Hospital and
Research Centre in Riyadh, Saudi Arabia from January 2005 till December
2015. Data pertaining to the patient demographics, disease,
transplant-related parameters and outcome was collected on a case report
form. Final dataset and analysis was performed in IBM-SPSS for Windows
after data cleaning and quality check.